{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [["cancer immunotherapy", "immune system", "nanovaccines"]], "InvestigatorList": [], "PMID": "39138855", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.1002/ddr.22244"], "Journal": {"ISSN": "1098-2299", "JournalIssue": {"Volume": "85", "Issue": "5", "PubDate": {"Year": "2024", "Month": "Aug"}}, "Title": "Drug development research", "ISOAbbreviation": "Drug Dev Res"}, "ArticleTitle": "Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy.", "Pagination": {"StartPage": "e22244", "MedlinePgn": "e22244"}, "Abstract": {"AbstractText": ["Nanovaccines have been designed to overcome the limitations associated with conventional vaccines. Effective delivery methods such as engineered carriers or smart nanoparticles (NPs) are critical requisites for inducing self-tolerance and optimizing vaccine immunogenicity with minimum side effects. NPs can be used as adjuvants, immunogens, or nanocarriers to develop nanovaccines for efficient antigen delivery. Multiloaded nanovaccines carrying multiple tumor antigens along with immunostimulants can effectively increase immunity against tumor cells. They can be biologically engineered to boost interactions with dendritic cells and to allow a gradual and constant antigen release. Modifying NPs surface properties, using high-density lipoprotein-mimicking nanodiscs, and developing nano-based artificial antigen-presenting cells such as dendritic cell-derived-exosomes are amongst the new developed technologies to enhance antigen-presentation and immune reactions against tumor cells. The present review provides an overview on the different perspectives, improvements, and barriers of successful clinical application of current cancer therapeutic and vaccination options. The immunomodulatory effects of different types of nanovaccines and the nanoparticles incorporated into their structure are described. The advantages of using nanovaccines to prevent and treat common illnesses such as AIDS, malaria, cancer and tuberculosis are discussed. Further, potential paths to develop optimal cancer vaccines are described. Given the immunosuppressive characteristics of both cancer cells and the tumor microenvironment, applying immunomodulators and immune checkpoint inhibitors in combination with other conventional anticancer therapies are necessary to boost the effectiveness of the immune response."], "CopyrightInformation": "\u00a9 2024 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Sciences, University of Maragheh, Maragheh, Iran."}], "LastName": "Jahanafrooz", "ForeName": "Zohreh", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products & Medicinal Plants Research Center, North Khorasan University of Medical Sciences Bojnurd, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Department of Medical Nanotechnology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Oroojalian", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Mokhtarzadeh", "ForeName": "Ahad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physics, Faculty of Sciences, University of Zabol, Zabol, Iran."}], "LastName": "Rahdar", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": ["0000-0001-7405-2354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad de Alcal\u00e1, Facultad de Ciencias, Departamento de Qu\u00edmica Anal\u00edtica, Qu\u00edmica F\u00edsica e Ingenieria Qu\u00edmica, Alcal\u00e1 de Henares, Spain."}], "LastName": "D\u00edez-Pascual", "ForeName": "Ana M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Drug Dev Res", "NlmUniqueID": "8204468", "ISSNLinking": "0272-4391"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cancer Vaccines"}, {"RegistryNumber": "0", "NameOfSubstance": "Antigens, Neoplasm"}, {"RegistryNumber": "0", "NameOfSubstance": "Nanovaccines"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Immunotherapy"}, {"QualifierName": ["immunology", "therapy", "drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["administration & dosage", "immunology"], "DescriptorName": "Cancer Vaccines"}, {"QualifierName": ["immunology", "administration & dosage"], "DescriptorName": "Antigens, Neoplasm"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Nanovaccines"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alfonsi, R., Grassi, L., Signore, M., & Bonci, D. (2018). The double face of exosome\u2010carried microRNAs in cancer immunomodulation. International Journal of Molecular Sciences, 19(4), 1183."}, {"Citation": "Alkayyal, A. A., Mahmoud, A. B., & Auer, R. C. (2016). Interleukin\u201012\u2010expressing oncolytic virus: A promising strategy for cancer immunotherapy. Journal of Taibah University Medical Sciences, 11(3), 187\u2013193."}, {"Citation": "Ayoub, N. M., Al\u2010Shami, K. M., & Yaghan, R. J. (2019). Immunotherapy for HER2\u2010positive breast cancer: Recent advances and combination therapeutic approaches. Breast Cancer: Targets and Therapy, 11, 53\u201369."}, {"Citation": "Bell, B. M., Kirk, I. D., Hiltbrunner, S., Gabrielsson, S., & Bultema, J. J. (2016). Designer exosomes as next\u2010generation cancer immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine, 12(1), 163\u2013169."}, {"Citation": "Berraondo, P., Sanmamed, M. F., Ochoa, M. C., Etxeberria, I., Aznar, M. A., P\u00e9rez\u2010Gracia, J. L., Rodr\u00edguez\u2010Ruiz, M. E., Ponz\u2010Sarvise, M., Casta\u00f1\u00f3n, E., & Melero, I. (2019). Cytokines in clinical cancer immunotherapy. British Journal of Cancer, 120(1), 6\u201315."}, {"Citation": "Besse, B., Charrier, M., Lapierre, V., Dansin, E., Lantz, O., Planchard, D., Le Chevalier, T., Livartoski, A., Barlesi, F., Laplanche, A., Ploix, S., Vimond, N., Peguillet, I., Th\u00e9ry, C., Lacroix, L., Zoernig, I., Dhodapkar, K., Dhodapkar, M., Viaud, S., \u2026 Chaput, N. (2016). Dendritic cell\u2010derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology, 5(4), e1071008."}, {"Citation": "Beygi, M., Oroojalian, F., Azizi\u2010Arani, S., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2024). Multifunctional nanotheranostics for overcoming the blood\u2013brain barrier. Advanced Functional Materials, 34, 2310881."}, {"Citation": "Beygi, M., Oroojalian, F., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2023). Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy. Progress in Materials Science, 140, 101209."}, {"Citation": "Bhardwaj, P., Bhatia, E., Sharma, S., Ahamad, N., & Banerjee, R. (2020). Advancements in prophylactic and therapeutic nanovaccines. Acta Biomaterialia, 108, 1\u201321."}, {"Citation": "Bloch, O., Crane, C. A., Fuks, Y., Kaur, R., Aghi, M. K., Berger, M. S., Butowski, N. A., Chang, S. M., Clarke, J. L., McDermott, M. W., Prados, M. D., Sloan, A. E., Bruce, J. N., & Parsa, A. T. (2014). Heat\u2010shock protein peptide complex\u201396 vaccination for recurrent glioblastoma: A phase II, single\u2010arm trial. Neuro\u2010Oncology, 16(2), 274\u2013279."}, {"Citation": "Braudeau, C., N\u00e9el, A., Amouriaux, K., Martin, J. C., Rimbert, M., Besan\u00e7on, A., Giraudet, S., Terrien, C., Aliaga, M., Salabert\u2010Le Guen, N., H\u00e9mont, C., Hamidou, M., & Josien, R. (2017). Dysregulated responsiveness of circulating dendritic cells to Toll\u2010like receptors in ANCA\u2010associated vasculitis. Frontiers in immunology, 8, 102."}, {"Citation": "van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643\u20131647."}, {"Citation": "Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017). Liposomal formulations in clinical use: An updated review. Pharmaceutics, 9(2), 12."}, {"Citation": "Cheever, M. A., & Higano, C. S. (2011). PROVENGE (Sipuleucel\u2010T) in prostate cancer: The first FDA\u2010approved therapeutic cancer vaccine. Clinical Cancer Research, 17(11), 3520\u20133526."}, {"Citation": "Chen, F., Wang, Y., Gao, J., Saeed, M., Li, T., Wang, W., & Yu, H. (2021). Nanobiomaterial\u2010based vaccination immunotherapy of cancer. Biomaterials, 270, 120709."}, {"Citation": "Chen, Q., Bao, Y., Burner, D., Kaushal, S., Zhang, Y., Mendoza, T., Bouvet, M., Ozkan, C., Minev, B., & Ma, W. (2019a). Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses. Drug Delivery and Translational Research, 9(6), 1095\u20131105."}, {"Citation": "Chen, Q., Xue, Y., & Sun, J. (2013). Kupffer cell\u2010mediated hepatic injury induced by silica nanoparticles in vitro and in vivo. International Journal of Nanomedicine, 8, 1129\u20131140."}, {"Citation": "Chen, S., Song, Z., & Zhang, A. (2019b). Small\u2010molecule immuno\u2010oncology therapy: Advances, challenges and new directions. Current Topics in Medicinal Chemistry, 19(3), 180\u2013185."}, {"Citation": "Chesson, C. B., & Zloza, A. (2017). Nanoparticles: Augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer. Nanomedicine, 12(23), 2693\u20132706."}, {"Citation": "Daneshmandi, S., Wegiel, B., & Seth, P. (2019). Blockade of lactate dehydrogenase\u2010a (LDH\u2010A) improves efficacy of anti\u2010programmed cell death\u20101 (PD\u20101) therapy in melanoma. Cancers, 11(4), 450."}, {"Citation": "Delcayre, A., Shu, H., & Le Pecq, J.\u2010B. (2005). Dendritic cell\u2010derived exosomes in cancer immunotherapy: Exploiting nature's antigen delivery pathway. Expert Review of Anticancer Therapy, 5(3), 537\u2013547."}, {"Citation": "Ding, B., Zheng, P., Jiang, F., Zhao, Y., Wang, M., Chang, M., Ma, P., & Lin, J. (2020). MnOx nanospikes as nanoadjuvants and immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect. Angewandte Chemie International Edition, 59(38), 16381\u201316384."}, {"Citation": "Diniz, F., Coelho, P., Duarte, H. O., Sarmento, B., Reis, C. A., & Gomes, J. (2022). Glycans as targets for drug delivery in cancer. Cancers, 14(4), 911."}, {"Citation": "Dong, X., Liang, J., Yang, A., Qian, Z., Kong, D., & Lv, F. (2019). A visible codelivery nanovaccine of antigen and adjuvant with self\u2010carrier for cancer immunotherapy. ACS Applied Materials & Interfaces, 11(5), 4876\u20134888."}, {"Citation": "Du, G., & Sun, X. (2020). Engineering nanoparticulate vaccines for enhancing antigen cross\u2010presentation. Current Opinion in Biotechnology, 66, 113\u2013122."}, {"Citation": "Du, X., Wang, J., Zhou, Q., Zhang, L., Wang, S., Zhang, Z., & Yao, C. (2018). Advanced physical techniques for gene delivery based on membrane perforation. Drug Delivery, 25(1), 1516\u20131525."}, {"Citation": "Duan, F., Duitama, J., Al Seesi, S., Ayres, C. M., Corcelli, S. A., Pawashe, A. P., Blanchard, T., McMahon, D., Sidney, J., Sette, A., Baker, B. M., Mandoiu, I. I., & Srivastava, P. K. (2014). Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. Journal of Experimental Medicine, 211(11), 2231\u20132248."}, {"Citation": "Duong, H. T. T., Yin, Y., Thambi, T., Nguyen, T. L., Giang Phan, V. H., Lee, M. S., Lee, J. E., Kim, J., Jeong, J. H., & Lee, D. S. (2018). Smart vaccine delivery based on microneedle arrays decorated with ultra\u2010pH\u2010responsive copolymers for cancer immunotherapy. Biomaterials, 185, 13\u201324."}, {"Citation": "Ehx, G., & Perreault, C. (2019). Discovery and characterization of actionable tumor antigens. Genome Medicine, 11(1), 29."}, {"Citation": "Elgueta, R., Benson, M. J., De Vries, V. C., Wasiuk, A., Guo, Y., & Noelle, R. J. (2009). Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunological Reviews, 229(1), 152\u2013172."}, {"Citation": "Escors, D. (2014). Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New Journal of Science, 2014, pii 1\u201325."}, {"Citation": "Escudier, B., Dorval, T., Chaput, N., Andr\u00e9, F., Caby, M.\u2010P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., Boccaccio, C., Bonnerot, C., Dhellin, O., Movassagh, M., Piperno, S., Robert, C., Serra, V., Valente, N., Le Pecq, J. B., \u2026 Zitvogel, L. (2005). Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived\u2010exosomes: Results of thefirst phase I clinical trial. Journal of Translational Medicine, 3(1), 10."}, {"Citation": "Esmaeil, N., Anaraki, S. B., Gharagozloo, M., & Moayedi, B. (2017). Silymarin impacts on immune system as an immunomodulator: One key for many locks. International Immunopharmacology, 50, 194\u2013201."}, {"Citation": "Fan, Y., & Moon, J. (2015). Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy. Vaccines, 3(3), 662\u2013685."}, {"Citation": "Fang, R. H., & Zhang, L. (2016). Nanoparticle\u2010based modulation of the immune system. Annual Review of Chemical And Biomolecular Engineering, 7, 305\u2013326."}, {"Citation": "Feichtinger, R. G., & Lang, R. (2019). Targeting L\u2010lactate metabolism to overcome resistance to immune therapy of melanoma and other tumor entities. Journal of Oncology, 2019, 2084195."}, {"Citation": "Fontana, F., Liu, D., Hirvonen, J., & Santos, H. A. (2017). Delivery of therapeutics with nanoparticles: What's new in cancer immunotherapy? WIREs Nanomedicine and Nanobiotechnology, 9(1), e1421."}, {"Citation": "Fu, B., Huang, X., Deng, J., Gu, D., Mei, Q., Deng, M., Tang, S., & L\u00fc, M. (2018). Application of multifunctional nanomaterials in cancer vaccines (Review). Oncology Reports, 39(3), 893\u2013900."}, {"Citation": "Gao, A., Chen, B., Gao, J., Zhou, F., Saeed, M., Hou, B., Li, Y., & Yu, H. (2019). Sheddable prodrug vesicles combating adaptive immune resistance for improved photodynamic immunotherapy of cancer. Nano Letters, 20(1), 353\u2013362."}, {"Citation": "Gao, H. (2016). Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharmaceutica Sinica B, 6(4), 268\u2013286."}, {"Citation": "Garcia\u2010Garijo, A., Fajardo, C. A., & Gros, A. (2019). Determinants for neoantigen identification. Frontiers in immunology, 10, 1392."}, {"Citation": "Gill, P. (2013). Nanocarriers, nanovaccines, and nanobacteria as nanobiotechnological concerns in modern vaccines. Scientia Iranica, 20(3), 1003\u20131013."}, {"Citation": "Glikin, G. C., & Finocchiaro, L. M. E. (2014). Clinical trials of immunogene therapy for spontaneous tumors in companion animals. The Scientific World Journal, 2014, 1\u201313."}, {"Citation": "Grunwitz, C., & Kranz, L. M. (2017). mRNA cancer vaccines\u2014Messages that prevail. Current Topics in Microbiology and Immunology, 405, 145\u2013164."}, {"Citation": "Guo, Y., Lei, K., & Tang, L. (2018). Neoantigen vaccine delivery for personalized anticancer immunotherapy. Frontiers in immunology, 9, 1499."}, {"Citation": "Hacohen, N., Fritsch, E. F., Carter, T. A., Lander, E. S., & Wu, C. J. (2013). Getting personal with neoantigen\u2010based therapeutic cancer vaccines. Cancer Immunology Research, 1(1), 11\u201315."}, {"Citation": "Hamilton, E., Blackwell, K., Hobeika, A. C., Clay, T. M., Broadwater, G., Ren, X.\u2010R., Chen, W., Castro, H., Lehmann, F., Spector, N., Wei, J., Osada, T., & Lyerly, H. K. (2012). Phase I clinical trial of HER2\u2010specific immunotherapy with concomitant HER2 kinase inhibtion. Journal of Translational Medicine, 10(1), 28."}, {"Citation": "Hanlon, D. J., Aldo, P. B., Devine, L., Alvero, A. B., Engberg, A. K., Edelson, R., & Mor, G. (2011). Enhanced stimulation of anti\u2010ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen. American Journal of Reproductive Immunology, 65(6), 597\u2013609."}, {"Citation": "Hashem Nia, A., Behnam, B., Taghavi, S., Oroojalian, F., Eshghi, H., Shier, W. T., Abnous, K., & Ramezani, M. (2017). Evaluation of chemical modification effects on DNA plasmid transfection efficiency of single\u2010walled carbon nanotube\u2013succinate\u2013polyethylenimine conjugates as non\u2010viral gene carriers. MedChemComm, 8(2), 364\u2013375."}, {"Citation": "He, C., Zheng, S., Luo, Y., & Wang, B. (2018). Exosome theranostics: Biology and translational medicine. Theranostics, 8(1), 237\u2013255."}, {"Citation": "Hoffmann, P. R., Hoffmann, F. W., Premeaux, T. A., Fujita, T., Soprana, E., Panigada, M., Chew, G. M., Richard, G., Hindocha, P., Menor, M., Khadka, V. S., Deng, Y., Moise, L., Ndhlovu, L. C., Siccardi, A., Weinberg, A. D., De Groot, A. S., & Bertino, P. (2019). Multi\u2010antigen vaccination with simultaneous engagement of the OX40 receptor delays malignant mesothelioma growth and increases survival in animal models. Frontiers in Oncology, 9, 720."}, {"Citation": "Huang, H., Liu, Y., Liao, W., Cao, Y., Liu, Q., Guo, Y., Lu, Y., & Xie, Z. (2019). Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy. Nature Communications, 10(1), 4801."}, {"Citation": "Jahanafrooz, Z., Baradaran, B., Mosafer, J., Hashemzaei, M., Rezaei, T., Mokhtarzadeh, A., & Hamblin, M. R. (2019a). Comparison of DNA and mRNA vaccines against cancer. Drug Discovery Today, pii S1359\u20136446(19), 30462\u201330463."}, {"Citation": "Jahanafrooz, Z., Mosafer, J., Akbari, M., Hashemzaei, M., Mokhtarzadeh, A., & Baradaran, B. (2019b). Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. Journal of Cellular Physiology, 235(5), 4153\u20134166."}, {"Citation": "Jahanafrooz, Z., Stallinger, A., Anders, I., Kleinegger, F., Lohberger, B., Durchschein, C., Bauer, R., Deutsch, A., Rinner, B., & Kretschmer, N. (2018). Influence of silibinin and \u03b2\u2010\u03b2\u2010dimethylacrylshikonin on chordoma cells. Phytomedicine, 49, 32\u201340."}, {"Citation": "Jiang, H., Wang, Q., & Sun, X. (2017). Lymph node targeting strategies to improve vaccination efficacy. Journal of Controlled Release, 267, 47\u201356."}, {"Citation": "Kakwere, H., Ingham, E. S., Allen, R., Mahakian, L. M., Tam, S. M., Zhang, H., Silvestrini, M. T., Lewis, J. S., & Ferrara, K. W. (2017). Toward personalized peptide\u2010based cancer nanovaccines: A facile and versatile synthetic approach. Bioconjugate Chemistry, 28(11), 2756\u20132771."}, {"Citation": "Kang, S., Ahn, S., Lee, J., Kim, J. Y., Choi, M., Gujrati, V., Kim, H., Kim, J., Shin, E. C., & Jon, S. (2017). Effects of gold nanoparticle\u2010based vaccine size on lymph node delivery and cytotoxic T\u2010lymphocyte responses. Journal of Controlled Release, 256, 56\u201367."}, {"Citation": "Karimi, M. A., Dadmehr, M., Hosseini, M., Korouzhdehi, B., & Oroojalian, F. (2019). Sensitive detection of methylated DNA and methyltransferase activity based on the lighting up of FAM\u2010labeled DNA quenched fluorescence by gold nanoparticles. RSC Advances, 9(21), 12063\u201312069."}, {"Citation": "Kelderman, S., & Kvistborg, P. (2016). Tumor antigens in human cancer control. Biochimica et Biophysica Acta (BBA) \u2010 Reviews on Cancer, 1865(1), 83\u201389."}, {"Citation": "Keskin, D. B., Anandappa, A. J., Sun, J., Tirosh, I., Mathewson, N. D., Li, S., Oliveira, G., Giobbie\u2010Hurder, A., Felt, K., Gjini, E., Shukla, S. A., Hu, Z., Li, L., Le, P. M., Alles\u00f8e, R. L., Richman, A. R., Kowalczyk, M. S., Abdelrahman, S., Geduldig, J. E., \u2026 Reardon, D. A. (2019). Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature, 565(7738), 234\u2013239."}, {"Citation": "Kiessling, A., Wehner, R., F\u00fcssel, S., Bachmann, M., Wirth, M. P., & Schmitz, M. (2012). Tumor\u2010associated antigens for specific immunotherapy of prostate cancer. Cancers, 4(1), 193\u2013217."}, {"Citation": "Knight, F. C., Gilchuk, P., Kumar, A., Becker, K. W., Sevimli, S., Jacobson, M. E., Suryadevara, N., Wang\u2010Bishop, L., Boyd, K. L., Crowe, J. E., Joyce, S., & Wilson, J. T. (2019). Mucosal immunization with a pH\u2010responsive nanoparticle vaccine induces protective CD8+ lung\u2010resident memory T cells. ACS Nano, 13(10), 10939\u201310960."}, {"Citation": "Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017). Designer vaccine nanodiscs for personalized cancer immunotherapy. Nature Materials, 16(4), 489\u2013496."}, {"Citation": "Kuai, R., Sun, X., Yuan, W., Xu, Y., Schwendeman, A., & Moon, J. J. (2018). Subcutaneous nanodisc vaccination with neoantigens for combination cancer immunotherapy. Bioconjugate Chemistry, 29(3), 771\u2013775."}, {"Citation": "Kumai, T., Kobayashi, H., Harabuchi, Y., & Celis, E. (2017). Peptide vaccines in cancer\u2010old concept revisited. Current Opinion in Immunology, 45, 1\u20137."}, {"Citation": "Kumari, P., Ghosh, B., & Biswas, S. (2016). Nanocarriers for cancer\u2010targeted drug delivery. Journal of Drug Targeting, 24(3), 179\u2013191."}, {"Citation": "Leleux, J., & Roy, K. (2013). Micro and nanoparticle\u2010based delivery systems for vaccine immunotherapy: An immunological and materials perspective. Advanced Healthcare Materials, 2(1), 72\u201394."}, {"Citation": "Li, W., Joshi, M., Singhania, S., Ramsey, K., & Murthy, A. (2014). Peptide vaccine: Progress and challenges. Vaccines, 2(3), 515\u2013536."}, {"Citation": "Li, Y., An, L., Lin, J., Tian, Q., & Yang, S. (2019a). Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S. International Journal of Nanomedicine, 14, 5729\u20135749."}, {"Citation": "Li, Y., Ayala\u2010Orozco, C., Rauta, P. R., & Krishnan, S. (2019b). The application of nanotechnology in enhancing immunotherapy for cancer treatment: Current effects and perspective. Nanoscale, 11(37), 17157\u201317178."}, {"Citation": "Li, Y., Patel, S. P., Roszik, J., & Qin, Y. (2018). Hypoxia\u2010driven immunosuppressive metabolites in the tumor microenvironment: New approaches for combinational immunotherapy. Frontiers in immunology, 9, 1591."}, {"Citation": "Lin, L. C. W., Chattopadhyay, S., Lin, J. C., & Hu, C. M. J. (2018). Advances and opportunities in nanoparticle\u2010and nanomaterial\u2010based vaccines against bacterial infections. Advanced Healthcare Materials, 7(13), 1701395."}, {"Citation": "Liu, H., Chen, L., Peng, Y., Yu, S., Liu, J., Wu, L., Zhang, L., Wu, Q., Chang, X., Yu, X., & Liu, T. (2018a). Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy. Oncotarget, 9(2), 2887."}, {"Citation": "Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014). Structure\u2010based programming of lymph\u2010node targeting in molecular vaccines. Nature, 507, 519\u2013522."}, {"Citation": "Liu, J., Liu, X., Han, Y., Zhang, J., Liu, D., Ma, G., Li, C., Liu, L., & Kong, D. (2018b). Nanovaccine incorporated with hydroxychloroquine enhances antigen cross\u2010presentation and promotes antitumor immune responses. ACS Applied Materials & Interfaces, 10(37), 30983\u201330993."}, {"Citation": "Liu, T., Li, L., Fu, C., Liu, H., Chen, D., & Tang, F. (2012). Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials, 33(7), 2399\u20132407."}, {"Citation": "Liu, W.\u2010L., Zou, M.\u2010Z., Liu, T., Zeng, J.\u2010Y., Li, X., Yu, W.\u2010Y., Li, X.\u2010X., Ye, J.\u2010J., Song, W., Feng, J., & Zhang, X.\u2010Z. (2019a). Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells. Nature Communications, 10(1), 1\u201312."}, {"Citation": "Liu, X., Feng, Z., Wang, C., Su, Q., Song, H., Zhang, C., Huang, P., Liang, X.\u2010J., Dong, A., Kong, D., & Wang, W. (2020a). Co\u2010localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T\u2010cellt responses. Biomaterials, 230, 119649."}, {"Citation": "Liu, Y., Wang, Y., Lv, Q., & Li, X. (2020b). Exosomes: From garbage bins to translational medicine. International Journal of Pharmaceutics, 583, 119333."}, {"Citation": "Liu, Y., Yao, L., Cao, W., Liu, Y., Zhai, W., Wu, Y., Wang, B., Gou, S., Qin, Y., Qi, Y., Chen, Z., & Gao, Y. (2019b). Dendritic cell targeting peptide\u2010based nanovaccines for enhanced cancer immunotherapy. ACS Applied Bio Materials, 2(3), 1241\u20131254."}, {"Citation": "Lopes, A., Vandermeulen, G., & Pr\u00e9at, V. (2019). Cancer DNA vaccines: Current preclinical and clinical developments and future perspectives. Journal of Experimental & Clinical Cancer Research, 38(1), 146."}, {"Citation": "Luby, T. M., Cole, G., Baker, L., Kornher, J. S., Ramstedt, U., & Hedley, M. L. (2004). Repeated immunization with plasmid DNA formulated in poly (lactide\u2010co\u2010glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor\u2010associated antigen cytochrome P450 1B1. Clinical Immunology, 112(1), 45\u201353."}, {"Citation": "Luo, M., Liu, Z., Zhang, X., Han, C., Samandi, L. Z., Dong, C., Sumer, B. D., Lea, J., Fu, Y. X., & Gao, J. (2019). Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy. Journal of Controlled Release, 300, 154\u2013160."}, {"Citation": "Luo, M., Wang, H., Wang, Z., Cai, H., Lu, Z., Li, Y., Du, M., Huang, G., Wang, C., Chen, X., Porembka, M. R., Lea, J., Frankel, A. E., Fu, Y. X., Chen, Z. J., & Gao, J. (2017). A STING\u2010activating nanovaccine for cancer immunotherapy. Nature Nanotechnology, 12(7), 648\u2013654."}, {"Citation": "Luo, Z., Wang, C., Yi, H., Li, P., Pan, H., Liu, L., Cai, L., & Ma, Y. (2015). Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti\u2010tumor immune responses through modulating tumor\u2010associated dendritic cells in vivo. Biomaterials, 38, 50\u201360."}, {"Citation": "Mahdavi, S. Z. B., Oroojalian, F., Eyvazi, S., Hejazi, M., Baradaran, B., Pouladi, N., Tohidkia, M. R., Mokhtarzadeh, A., & Muyldermans, S. (2022). An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages. International Journal of Biological Macromolecules, 208, 421\u2013442."}, {"Citation": "Mahjub, R., Jatana, S., Lee, S. E., Qin, Z., Pauli, G., Soleimani, M., Madadi, S., & Li, S. D. (2018). Recent advances in applying nanotechnologies for cancer immunotherapy. Journal of Controlled Release, 288, 239\u2013263."}, {"Citation": "Makidon, P. E., Knowlton, J., Groom, J. V., Blanco, L. P., LiPuma, J. J., Bielinska, A. U., & Baker, J. R. (2010). Induction of immune response to the 17\u2009kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion\u2010based vaccine. Medical Microbiology and Immunology, 199(2), 81\u201392."}, {"Citation": "Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., & Eisenbach, L. (1994). CTL induction by a tumour\u2010associated antigen octapeptide derived from a murine lung carcinoma. Nature, 369, 67\u201371."}, {"Citation": "Mandelboim, O., Vadai, E., Fridkin, M., Katz\u2010Hillel, A., Feldman, M., Berke, G., & Eisenbach, L. (1995). Regression of established murine carcinoma metastases following vaccination with tumour\u2010associated antigen peptides. Nature Medicine, 1, 1179\u20131183."}, {"Citation": "Martinez M., Moon E. K. (2019). CAR T cells for solid tumors: New strategies for finding, infiltrating, and surviving in the tumor microenvironment. Frontiers in Immunology. 10, 128."}, {"Citation": "McKeever, U., Barman, S., Hao, T., Chambers, P., Song, S., Lunsford, L., Hsu, Y. Y., Roy, K., & Hedley, M. L. (2002). Protective immune responses elicited in mice by immunization with formulations of poly (lactide\u2010co\u2010glycolide) microparticles. Vaccine, 20(11\u201312), 1524\u20131531."}, {"Citation": "Miliotou, A. N., & Papadopoulou, L. C. (2018). CAR T\u2010cell therapy: A new era in cancer immunotherapy. Current Pharmaceutical Biotechnology, 19(1), 5\u201318."}, {"Citation": "Mohammed, S., Bakshi, N., Chaudri, N., Akhter, J., & Akhtar, M. (2016). Cancer vaccines: Past, present, and future. Advances in Anatomic Pathology, 23(3), 180\u2013191."}, {"Citation": "Mohsen, M. O., Vogel, M., Riether, C., Muller, J., Salatino, S., Ternette, N., Gomes, A. C., Cabral\u2010Miranda, G., El\u2010Turabi, A., Ruedl, C., Kundig, T. M., Dermime, S., Knuth, A., Speiser, D. E., & Bachmann, M. F. (2019). Targeting mutated plus germline epitopes confers pre\u2010clinical efficacy of an instantly formulated cancer nano\u2010vaccine. Frontiers in Immunology, 10, 1015."}, {"Citation": "Molino, N. M., Neek, M., Tucker, J. A., Nelson, E. L., & Wang, S.\u2010W. (2016). Viral\u2010mimicking protein nanoparticle vaccine for eliciting anti\u2010tumor responses. Biomaterials, 86, 83\u201391."}, {"Citation": "Mou, J., Bolieu, E. L., Pflugeisen, B. M., Amoroso, P. J., Devine, B., Baldwin, L. M., Frank, L. L., & Johnson, R. H. (2019). Delay in treatment after cancer diagnosis in adolescents and young adults: Does facility transfer matter? Journal of Adolescent and Young Adult Oncology, 8(3), 243\u2013253."}, {"Citation": "Nguyen, F., Alferiev, I., Guan, P., Guerrero, D. T., Kolla, V., Moorthy, G. S., Chorny, M., & Brodeur, G. M. (2018). Enhanced intratumoral delivery of SN38 as a tocopherol oxyacetate prodrug using nanoparticles in a neuroblastoma xenograft model. Clinical Cancer Research, 24(11), 2585\u20132593."}, {"Citation": "Niu, L., Chu, L. Y., Burton, S. A., Hansen, K. J., & Panyam, J. (2019). Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. Journal of Controlled Release, 294, 268\u2013278."}, {"Citation": "Noh, Y. W., Kim, S. Y., Kim, J. E., Kim, S., Ryu, J., Kim, I., Lee, E., Um, S. H., & Lim, Y. T. (2017). Multifaceted immunomodulatory nanoliposomes: Reshaping tumors into vaccines for enhanced cancer immunotherapy. Advanced Functional Materials, 27(8), 1605398."}, {"Citation": "Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R. & Blankschtein, D. (2017). Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy Nano Letters, 17(3), 1326\u20131335."}, {"Citation": "Oroojalian, F., Karimzadeh, S., Javanbakht, S., Hejazi, M., Baradaran, B., Webster, T. J., Mokhtarzadeh, A., Varma, R. S., Kesharwani, P., & Sahebkar, A. (2022). Current trends in stimuli\u2010responsive nanotheranostics based on metal\u2013organic frameworks for cancer therapy. Materials Today, 57, 192\u2013224."}, {"Citation": "Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie\u2010Hurder, A., Peter, L., Chen, C., Olive, O., Carter, T. A., Wu, C. J., Li, S., Lieb, D. J., Eisenhaure, T., Gjini, E., Stevens, J., Lane, W. J., \u2026 Wu, C. J. (2017). An immunogenic personal neoantigen vaccine for patients with melanoma. Nature, 547(7662), 217\u2013221."}, {"Citation": "Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines\u2014A new era in vaccinology. Nature Reviews Drug Discovery, 17(4), 261\u2013279."}, {"Citation": "Parhi, P., Mohanty, C., & Sahoo, S. K. (2012). Nanotechnology\u2010based combinational drug delivery: An emerging approach for cancer therapy. Drug Discovery Today, 17(17\u201318), 1044\u20131052."}, {"Citation": "Park, J. E., Dutta, B., Tse, S. W., Gupta, N., Tan, C. F., Low, J. K., Yeoh, K. W., Kon, O. L., Tam, J. P., & Sze, S. K. (2019). Hypoxia\u2010induced tumor exosomes promote M2\u2010like macrophage polarization of infiltrating myeloid cells and microRNA\u2010mediated metabolic shift. Oncogene, 38(26), 5158\u20135173."}, {"Citation": "Park, W., Heo, Y. J., & Han, D. K. (2018). New opportunities for nanoparticles in cancer immunotherapy. Biomaterials Research, 22, 24."}, {"Citation": "Paterson, Y., Guirnalda, P. D., & Wood, L. M. (2010). Listeria and Salmonella bacterial vectors of tumor\u2010associated antigens for cancer immunotherapy. Seminars in Immunology, 22(3), 183\u2013189."}, {"Citation": "Le Pecq, J.\u2010B. (2005). Dexosomes as a therapeutic cancer vaccine: From bench to bedside. Blood Cells, Molecules, and Diseases, 35(2), 129\u2013135."}, {"Citation": "Pejawar\u2010Gaddy, S., Rajawat, Y., Hilioti, Z., Xue, J., Gaddy, D. F., Finn, O. J., Viscidi, R. P., & Bossis, I. (2010). Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus\u2010like particles. Cancer Immunology, Immunotherapy, 59(11), 1685\u20131696."}, {"Citation": "Pishavar, E., Oroojalian, F., Salmasi, Z., Hashemi, E., & Hashemi, M. (2021). Recent advances of dendrimer in targeted delivery of drugs and genes to stem cells as cellular vehicles. Biotechnology Progress, 37(4), e3174."}, {"Citation": "Pulendran, B., & Ahmed, R. (2011). Immunological mechanisms of vaccination. Nature Immunology, 12(6), 509\u2013517."}, {"Citation": "Racz, R., Li, X., Patel, M., Xiang, Z., & He, Y. (2014). DNAVaxDB: The first web\u2010based DNA vaccine database and its data analysis. BMC Bioinformatics, 15(S4), S2."}, {"Citation": "Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018). New vaccine technologies to combat outbreak situations. Frontiers in immunology, 9, 1963."}, {"Citation": "Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006). In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. Journal of Controlled Release, 112(1), 26\u201334."}, {"Citation": "Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019). Delivery technologies for cancer immunotherapy. Nature Reviews Drug Discovery, 18(3), 175\u2013196."}, {"Citation": "Rountree, R. B., Mandl, S. J., Nachtwey, J. M., Dalpozzo, K., Do, L., Lombardo, J. R., Schoonmaker, P. L., Brinkmann, K., Dirmeier, U., Laus, R., & Delcayre, A. (2011). Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficac. Cancer Research, 71(15), 5235\u20135244."}, {"Citation": "Rueda, F., Eich, C., Cordobilla, B., Domingo, P., Acosta, G., Albericio, F., Cruz, L. J., & Domingo, J. C. (2017). Effect of TLR ligands co\u2010encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccines. Immunobiology, 222(11), 989\u2013997."}, {"Citation": "Sacchetti, C., Rapini, N., Magrini, A., Cirelli, E., Bellucci, S., Mattei, M., Rosato, N., Bottini, N., & Bottini, M. (2013). In vivo targeting of intratumor regulatory T cells using PEG\u2010modified single\u2010walled carbon nanotubes. Bioconjugate Chemistry, 24(6), 852\u2013858."}, {"Citation": "Saga, K., & Kaneda, Y. (2013). Virosome presents multimodel cancer therapy without viral replication. BioMed Research International, 2013, 764706."}, {"Citation": "Sahin, U., Derhovanessian, E., Miller, M., Kloke, B. P., Simon, P., L\u00f6wer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schr\u00f6rs, B., Omokoko, T., Vormehr, M., Albrecht, C., Paruzynski, A., Kuhn, A. N., Buck, J., Heesch, S., Schreeb, K. H., M\u00fcller, F., \u2026 T\u00fcreci, \u00d6. (2017). Personalized RNA mutanome vaccines mobilize poly\u2010specific therapeutic immunity against cancer. Nature, 547(7662), 222\u2013226."}, {"Citation": "Saluja, S. S., Hanlon, D. J., Sharp, F. A., Hong, E., Khalil, D., Robinson, E., Tigelaar, R., Fahmy, T. M., & Edelson, R. L. (2014). Targeting human dendritic cells via DEC\u2010205 using PLGA nanoparticles leads to enhanced cross\u2010presentation of a melanoma\u2010associated antigen. International Journal of Nanomedicine, 9, 5231\u20135246."}, {"Citation": "Samstein, R. M., Lee, C. H., Shoushtari, A. N., Hellmann, M. D., Shen, R., Janjigian, Y. Y., Barron, D. A., Zehir, A., Jordan, E. J., Omuro, A., Kaley, T. J., Kendall, S. M., Motzer, R. J., Hakimi, A. A., Voss, M. H., Russo, P., Rosenberg, J., Iyer, G., Bochner, B. H., \u2026 Morris, L. G. T. (2019). Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature Genetics, 51(2), 202\u2013206."}, {"Citation": "Santos, P. M., & Butterfield, L. H. (2018). Dendritic cell\u2010based cancer vaccines. The Journal of Immunology, 200(2), 443\u2013449."}, {"Citation": "Sartorius, R., D'Apice, L., Barba, P., Cipria, D., Grauso, L., Cutignano, A., & De Berardinis, P. (2018). Vectorized delivery of alpha\u2010GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor\u2010specific T cell response. Frontiers in immunology, 9, 1496."}, {"Citation": "Sathyanarayanan, V., & Neelapu, S. S. (2015). Cancer immunotherapy: Strategies for personalization and combinatorial approaches. Molecular oncology, 9(10), 2043\u20132053."}, {"Citation": "Schudel, A., Chapman, A. P., Yau, M.\u2010K., Higginson, C. J., Francis, D. M., Manspeaker, M. P., Avecilla, A. R. C., Rohner, N. A., Finn, M. G., & Thomas, S. N. (2020). Programmable multistage drug delivery to lymph nodes. Nature Nanotechnology, 15(6), 491\u2013499."}, {"Citation": "Scolnick, E. M. (2018). A vaccine to prevent cervical cancer: academic and industrial collaboration and a Lasker award. Clinical & Translational Immunology, 7(1), e1002."}, {"Citation": "Shae, D., Baljon, J. J., Wehbe, M., Christov, P. P., Becker, K. W., Kumar, A., Suryadevara, N., Carson, C. S., Palmer, C. R., Knight, F. C., Joyce, S., & Wilson, J. T. (2020). Co\u2010delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines. ACS Nano, 14(8), 9904\u20139916."}, {"Citation": "Shahgordi, S., Oroojalian, F., Hashemi, E., & Hashemi, M. (2022). Recent advances in development of nano\u2010carriers for immunogene therapy in various complex disorders. Iranian Journal of Basic Medical Sciences, 25(2), 134\u2013147."}, {"Citation": "Shevtsov, M., & Multhoff, G. (2016). Heat shock protein\u2013peptide and HSP\u2010based immunotherapies for the treatment of cancer. Frontiers in immunology, 7, 171."}, {"Citation": "Shi, Y., & Lammers, T. (2019). Combining nanomedicine and immunotherapy. Accounts of Chemical Research, 52(6), 1543\u20131554."}, {"Citation": "Shukla, G. S., Sun, Y.\u2010J., Pero, S. C., Sholler, G. S., & Krag, D. N. (2018). Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine\u2010draining lymph node B cell responses. Journal of Immunological Methods, 460, 51\u201362."}, {"Citation": "Shukla, S., & Steinmetz, N. F. (2016). Emerging nanotechnologies for cancer immunotherapy. Experimental Biology and Medicine, 241(10), 1116\u20131126."}, {"Citation": "Shvedova, A. A., Kisin, E. R., Mercer, R., Murray, A. R., Johnson, V. J., Potapovich, A. I., Tyurina, Y. Y., Gorelik, O., Arepalli, S., Schwegler\u2010Berry, D., Hubbs, A. F., Antonini, J., Evans, D. E., Ku, B. K., Ramsey, D., Maynard, A., Kagan, V. E., Castranova, V., & Baron, P. (2005). Unusual inflammatory and fibrogenic pulmonary responses to single\u2010walled carbon nanotubes in mice. American Journal of Physiology\u2010Lung Cellular and Molecular Physiology, 289(5), L698\u2013L708."}, {"Citation": "Sun, Q., Barz, M., De Geest, B. G., Diken, M., Hennink, W. E., Kiessling, F., Lammers, T., & Shi, Y. (2019). Nanomedicine and macroscale materials in immuno\u2010oncology. Chemical Society Reviews, 48(1), 351\u2013381."}, {"Citation": "Suschak, J. J., Williams, J. A., & Schmaljohn, C. S. (2017). Advancements in DNA vaccine vectors, non\u2010mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Human Vaccines & Immunotherapeutics, 13(12), 2837\u20132848."}, {"Citation": "Syn, N. L., Wang, L., Chow, E. K.\u2010H., Lim, C. T., & Goh, B.\u2010C. (2017). Exosomes in cancer nanomedicine and immunotherapy: Prospects and challenges. Trends in Biotechnology, 35(7), 665\u2013676."}, {"Citation": "Tagliamonte, M., Petrizzo, A., Tornesello, M. L., Buonaguro, F. M., & Buonaguro, L. (2014). Antigen\u2010specific vaccines for cancer treatment. Human Vaccines & Immunotherapeutics, 10(11), 3332\u20133346."}, {"Citation": "Tandrup Schmidt, S., Foged, C., Smith Korsholm, K., Rades, T., & Christensen, D. (2016). Liposome\u2010based adjuvants for subunit vaccines: Formulation strategies for subunit antigens and immunostimulators. Pharmaceutics, 8(1), 7."}, {"Citation": "Ter\u00e1n\u2010Navarro, H., Calderon\u2010Gonzalez, R., Salcines\u2010Cuevas, D., Garc\u00eda, I., Marradi, M., Freire, J., Salmon, E., Portillo\u2010Gonzalez, M., Frande\u2010Cabanes, E., Garc\u00eda\u2010Casta\u00f1o, A., Martinez\u2010Callejo, V., Gomez\u2010Roman, J., Tobes, R., Rivera, F., Ya\u00f1ez\u2010Diaz, S., & \u00c1lvarez\u2010Dom\u00ednguez, C. (2019). Pre\u2010clinical development of listeria\u2010based nanovaccines as immunotherapies for solid tumours: Insights from melanoma. Oncoimmunology, 8(2), e1541534."}, {"Citation": "Terbuch, A., & Lopez, J. (2018). Next generation cancer vaccines\u2010make it personal! Vaccines, 6(3), 52."}, {"Citation": "Th\u00e9ry, C., Ostrowski, M., & Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nature Reviews Immunology, 9(8), 581\u2013593."}, {"Citation": "Thomas, R., Al\u2010Khadairi, G., Roelands, J., Hendrickx, W., Dermime, S., Bedognetti, D., & Decock, J. (2018). NY\u2010ESO\u20101 based immunotherapy of cancer: Current perspectives. Frontiers in immunology, 9, 947."}, {"Citation": "Thomas, S., & Prendergast, G. C. (2016). Cancer vaccines: A brief overview. Methods in Molecular Biology, 1403, 755\u2013761."}, {"Citation": "Tiptiri\u2010Kourpeti, A., Spyridopoulou, K., Pappa, A., & Chlichlia, K. (2016). DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy. Pharmacology & Therapeutics, 165, 32\u201349."}, {"Citation": "Toussaint, B., Chauchet, X., Wang, Y., Polack, B., & Gou\u00ebllec, A. L. (2013). Live\u2010attenuated bacteria as a cancer vaccine vector. Expert Review of Vaccines, 12(10), 1139\u20131154."}, {"Citation": "Trung, L. Q., & An, D. T. T. (2018). Is resveratrol a cancer immunomodulatory molecule? Frontiers in Pharmacology, 9, 1255."}, {"Citation": "Tsoras, A. N., & Champion, J. A. (2019). Protein and peptide biomaterials for engineered subunit vaccines and immunotherapeutic applications. Annual Review of Chemical and Biomolecular Engineering, 10, 337\u2013359."}, {"Citation": "Uthaman, S., Huh, K. M., & Park, I. K. (2018). Tumor microenvironment\u2010responsive nanoparticles for cancer theragnostic applications. Biomaterials Research, 22, 22."}, {"Citation": "Utsugi\u2010Kobukai, S., Fujimaki, H., Hotta, C., Nakazawa, M., & Minami, M. (2003). MHC class I\u2010mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunology Letters, 89(2\u20133), 125\u2013131."}, {"Citation": "Verdura, S., Cuy\u00e0s, E., Llorach\u2010Par\u00e9s, L., P\u00e9rez\u2010S\u00e1nchez, A., Micol, V., Nonell\u2010Canals, A., Joven, J., Valiente, M., S\u00e1nchez\u2010Mart\u00ednez, M., Bosch\u2010Barrera, J., & Menendez, J. A. (2018). Silibinin is a direct inhibitor of STAT3. Food and Chemical Toxicology, 116(Pt B), 161\u2013172."}, {"Citation": "Viaud, S., Ploix, S., Lapierre, V., Th\u00e9ry, C., Commere, P.\u2010H., Tramalloni, D., Gorrichon, K., Virault\u2010Rocroy, P., Tursz, T., Lantz, O., Zitvogel, L., & Chaput, N. (2011). Updated technology to produce highly immunogenic dendritic cell\u2010derived exosomes of clinical grade: A critical role of interferon\u2010\u03b3. Journal of Immunotherapy, 34(1), 65\u201375."}, {"Citation": "Wagner, S., Mullins, C. S., & Linnebacher, M. (2018). Colorectal cancer vaccines: Tumor\u2010associated antigens vs neoantigens. World Journal of Gastroenterology, 24(48), 5418\u20135432."}, {"Citation": "Wang, D., Wang, T., Yu, H., Feng, B., Zhou, L., Zhou, F., Hou, B., Zhang, H., Luo, M., & Li, Y. (2019a). Engineering nanoparticles to locally activate T cells in the tumor microenvironment. Science immunology, 4(37), eaau6584."}, {"Citation": "Wang, S., Gao, J., & Wang, Z. (2019b). Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 11(2), e1523."}, {"Citation": "Wang, Y., Zhang, L., Xu, Z., Miao, L., & Huang, L. (2018). mRNA vaccine with antigen\u2010specific checkpoint blockade induces an enhanced immune response against established melanoma. Molecular Therapy, 26(2), 420\u2013434."}, {"Citation": "Wargowski, E., Johnson, L. E., Eickhoff, J. C., Delmastro, L., Staab, M. J., Liu, G., & McNeel, D. G. (2018). Prime\u2010boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration\u2010resistant prostate cancer (mCRPC) using Sipuleucel\u2010T and a DNA vaccine. Journal for Immunotherapy of Cancer, 6(1), 21."}, {"Citation": "Weon, J. L., & Potts, P. R. (2015). The MAGE protein family and cancer. Current Opinion in Cell Biology, 37, 1\u20138."}, {"Citation": "Wiedermann, U., Wiltschke, C., Jasinska, J., Kundi, M., Zurbriggen, R., Garner\u2010Spitzer, E., Bartsch, R., Steger, G., Pehamberger, H., Scheiner, O., & Zielinski, C. C. (2010). A virosomal formulated Her\u20102/neu multi\u2010peptide vaccine induces Her\u20102/neu\u2010specific immune responses in patients with metastatic breast cancer: A phase I study. Breast Cancer Research and Treatment, 119, 673\u2013683."}, {"Citation": "Wold, W., & Toth, K. (2014). Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Current Gene Therapy, 13(6), 421\u2013433."}, {"Citation": "Wu, Y.\u2010L., Park, K., Soo, R. A., Sun, Y., Tyroller, K., Wages, D., Ely, G., Yang, J. C. H., & Mok, T. (2011). INSPIRE: A phase III study of the BLP25 liposome vaccine (L\u2010BLP25) in asian patients with unresectable stage III non\u2010small cell lung cancer. BMC Cancer, 11(1), 430."}, {"Citation": "Xu, Z., Ramishetti, S., Tseng, Y. C., Guo, S., Wang, Y., & Huang, L. (2013). Multifunctional nanoparticles co\u2010delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T\u2010lymphocyte response against melanoma and its lung metastasis. Journal of Controlled Release, 172(1), 259\u2013265."}, {"Citation": "Yadav, H. K. S., Dibi, M., Mohammad, A., & Srouji, A. E. (2018). Nanovaccines formulation and applications\u2010a review. Journal of Drug Delivery Science and Technology, 44, 380\u2013387."}, {"Citation": "Yang, B., Jeang, J., Yang, A., Wu, T. C., & Hung, C. F. (2014). DNA vaccine for cancer immunotherapy. Human Vaccines & Immunotherapeutics, 10(11), 3153\u20133164."}, {"Citation": "Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018). Cancer cell membrane\u2010coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination. ACS Nano, 12(6), 5121\u20135129."}, {"Citation": "Yin, Z., Wu, X., Kaczanowska, K., Sungsuwan, S., Comellas Aragones, M., Pett, C., Yu, J., Baniel, C., Westerlind, U., Finn, M. G., & Huang, X. (2018). Antitumor humoral and T cell responses by Mucin\u20101 conjugates of bacteriophage Q\u03b2 in wild\u2010type mice. ACS Chemical Biology, 13(6), 1668\u20131676."}, {"Citation": "Yoon, H. Y., Selvan, S. T., Yang, Y., Kim, M. J., Yi, D. K., Kwon, I. C., & Kim, K. (2018). Engineering nanoparticle strategies for effective cancer immunotherapy. Biomaterials, 178, 597\u2013607."}, {"Citation": "Zang, X. (2018). 2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade \u2013 A personal account. Genes & Diseases, 5(4), 302\u2013303."}, {"Citation": "Zang, X., Zhao, X., Hu, H., Qiao, M., Deng, Y., & Chen, D. (2017). Nanoparticles for tumor immunotherapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 243\u2013256."}, {"Citation": "Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., Coussens, L. M., & Daldrup\u2010Link, H. E. (2016). Iron oxide nanoparticles inhibit tumour growth by inducing pro\u2010inflammatory macrophage polarization in tumour tissues. Nature Nanotechnology, 11(11), 986\u2013994."}, {"Citation": "Zhang, H., Chen, Z., Du, M., Li, Y., & Chen, Y. (2018a). Enhanced gene transfection efficiency by low\u2010dose 25\u2009kDa polyethylenimine by the assistance of 1.8\u2009kDa polyethylenimine. Drug Delivery, 25(1), 1740\u20131745."}, {"Citation": "Zhang, L. X., Xie, X. X., Liu, D. Q., Xu, Z. P., & Liu, R. T. (2018b). Efficient co\u2010delivery of neo\u2010epitopes using dispersion\u2010stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy. Biomaterials, 174, 54\u201366."}, {"Citation": "Zhang, R., Zhang, X., Ma, B., Xiao, B., Huang, F., Huang, P., Ying, C., Liu, T., & Wang, Y. (2016). Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA\u2010controlled oncolytic adenovirus in lung cancer. Cancer Gene Therapy, 23, 168\u2013177."}, {"Citation": "Zheng, M., Huang, J., Tong, A., & Yang, H. (2019). Oncolytic viruses for cancer therapy: Barriers and recent advances. Molecular Therapy \u2010 Oncolytics, 15, 234\u2013247."}, {"Citation": "Zhuang, Y., Ma, Y., Wang, C., Hai, L., Yan, C., Zhang, Y., Liu, F., & Cai, L. (2012). PEGylated cationic liposomes robustly augment vaccine\u2010induced immune responses: Role of lymphatic trafficking and biodistribution. Journal of Controlled Release, 159(1), 135\u2013142."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2024", "Month": "4", "Day": "16"}, {"Year": "2024", "Month": "1", "Day": "19"}, {"Year": "2024", "Month": "7", "Day": "29"}, {"Year": "2024", "Month": "8", "Day": "14", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "8", "Day": "14", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "8", "Day": "14", "Hour": "1", "Minute": "32"}], "PublicationStatus": "ppublish", "ArticleIdList": ["39138855", "10.1002/ddr.22244"]}}]}